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Background Investigations using a hybrid single photon
emission computed tomography/computed tomography
(SPECT-CT) scanning technique have been carried out in
limited studies and have shown mixed results. However,
the assessment of this technique for the detection of
parathyroid adenoma in patients with a nodular goiter was
performed in only one study with a small sample size.
The aim of this prospective study was to assess the role
of 99mTc-sestamibi parathyroid SPECT-CT scans for
localization of parathyroid adenomas with a concomitant
nodular goiter using 99mTc-methoxyisobutyl isonitrile
(MIBI) scintigraphy and to compare it with SPECT and
planar imaging.
Methods This study was conducted on 48 patients with
primary hyperparathyroidism and nodular goiter, who were
candidates for parathyroid surgery and had been referred
for parathyroid scintigraphy. The patients underwent an
early set of planar 99mTc-MIBI scanning procedures first,
followed by SPECT and CT scannings, and finally a delayed
set of planar 99mTc-MIBI scannings. Sensitivity, specificity,
negative and positive predictive values, and accuracy
were determined on a per-parathyroid-gland basis
for each scanning method, as defined by histology and
follow-up.
Results The surgery was successful in 48 out of 50
patients with primary hyperparathyroidism concomitant
with thyroid nodularity, and data were completed for 80
sites in 48 patients. The accuracy of SPECT-CT in correctly
identifying a parathyroid adenoma was 85.00, versus
75.00% for SPECT (P=0.01, significant). The sensitivity
and specificity for SPECT-CT were 77.55 and 96.77%,
respectively, versus 67.34 and 87.09%, respectively, for
SPECT (P=0.12 and 0.12, not significant). There were nine
sites that showed better localization on SPECT-CT scans
relative to SPECT images, of which five sites were located
in the ectopic regions.
Conclusion The results of our study indicate that
SPECT-CT is more accurate than sestamibi planar
imaging and SPECT for the preoperative identification of
parathyroid lesions in patients with primary
hyperparathyroidism concomitant with thyroid nodularity.
Also, we would recommend the use of SPECT-CT for
a workup of all patients with ectopic glands who
are scheduled for minimally invasive parathyroid
surgery. Nucl Med Commun 33:1070–1076 c 2012 Wolters
Kluwer Health | Lippincott Williams & Wilkins.
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Introduction
Bilateral neck exploration as the traditional surgical
approach in patients with primary hyperparathyroidism
has been replaced recently by limited surgical proce-
dures, such as unilateral neck exploration, minimally
invasive parathyroidectomy, and endoscopic surgery,
which are feasible only with preoperative localization of
a solitary parathyroid adenoma [1].
In addition, the diagnostic imaging methods for para-
thyroid localization have progressed greatly, allowing
identification and localization of obscure and ectopic
abnormal parathyroid glands before parathyroid surgery,
which increases successful surgical manipulation and
decreases the need for reoperation [2].
Most studies demonstrate the superior accuracy of single
photon emission computed tomography (SPECT) ima-
ging for the detection and localization of hyperfunctioning
parathyroids, as compared with the planar method [3–6],
but this was not seen in all previous investigations [7,8].
In addition, there is a wide variety of parathyroid
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scintigraphy protocols: a single set of SPECT images,
either early or delayed [4,8]; a dual-phase SPECT [9,10];
a pinhole SPECT [11]; and the planar method.
The integration of computed tomography (CT) with
SPECT, either by off-line software fusion [12] or by
hybrid SPECT-CT techniques [10,13], has the potential
to improve the accuracy of parathyroid scintigraphy [14].
Investigations using hybrid SPECT-CT techniques have
been carried out in limited studies and have shown
controversial results [10,13]. However, the assessment of
this technique in the detection of parathyroid adenoma in
patients with a nodular goiter was performed in only one
study with a small sample size [15].
The aim of this prospective study was to assess the role of
99mTc-sestamibi parathyroid SPECT-CT in the localiza-
tion of parathyroid adenomas with concomitant nodular
goiter using 99mTc-methoxyisobutyl isonitrile (MIBI)




This study was conducted on 97 patients with primary
hyperparathyroidism who were candidates for parathyroid
surgery and had been referred to the nuclear medicine
department of Erfan hospital for parathyroid scintigraphy.
Endocrine specialists confirmed primary hyperparathy-
roidism in accordance with their history and laboratory
test values [parathyroid hormone (PTH), Ca, P, Cr, and 25-
hydroxy-vitamin D3]. The patients were recruited from
some clinics and university hospitals in Tehran between May
2009 and August 2010. They underwent early planar 99mTc-
MIBI scanning first, followed by SPECT, CT, and finally a
set of delayed planar 99mTc-MIBI scanning procedures.
Before scintigraphy, all patients underwent a careful
physical examination to detect the presence of palpable
thyroid nodules, and 50 patients with a nodular goiter
were included in this study.
The study complies with the Declaration of Helsinki and
was approved by the institutional ethics committee of
Shahid Beheshti University of Medical Science; all
patients gave their written informed consent.
Imaging protocols
The patients received 740MBq (20mCi) of 99mTc-MIBI
by intravenous injection. Anterior planar projections of
the neck and chest were acquired 20 and 120min after
the administration, each time for a 10-min duration, using
a high-resolution low-energy parallel hole collimator and a
large-field-of-view dual-detector camera with a mounted
CT scanner (Symbia-T; Siemens Medical Systems,
Erlangen, Germany). SPECT images of the same area
were obtained immediately after the planar acquisition at
20min after administration, using 60 frames at 25 s/frame
and 31 angles, under a step-and-shoot protocol. The
images were compiled into a 128 128 matrix and
reconstructed by a two-dimensional ordered-subset
expectation maximization iterative method (four subsets
and eight iterations). The CT part was acquired at a slice
step of 2mm, a current of 20mA, and a voltage of 130 kV,
after implementation of SPECT.
Image interpretation
Scintigraphic data were interpreted by three nuclear
medicine specialists, with differences in judgment re-
solved by consensus. They read the images while being
unaware of any clinical or laboratory information about
the patients. Each finding was allocated an anatomic
location and scored on a three-point scale of diagnostic
impression (1, negative; 2, equivocal; 3, positive) for
a parathyroid lesion. A discrete focus of increased MIBI
activity in the neck, or focal uptake in the mediastinum,
was considered positive for a parathyroid adenoma on
scintigraphy. The readers sequentially scored the planar
images, the SPECT images, and finally the SPECT/CT
images for each patient.
Bilateral or unilateral surgical neck exploration was
carried out for each patient by experienced parathyroid
surgeons. The choice of the surgical method was made
according to preoperative localization findings and/or the
surgeon’s practice. An attempt to recognize all parathy-
roid glands was made at the time of surgery, and the
location of abnormal parathyroid glands, gross surgical
findings, size of excised parathyroid glands, and histo-
pathologic findings were recorded.
Surgical cure was approved by histopathologic verifica-
tion of the removed abnormal parathyroid tissue, with a
decrease in serum calcium and PTH levels to the normal
range.
Statistical analysis
The data are presented as mean±SD. To estimate the
statistical parameters for each of the three imaging
techniques, scores 1 and 2 were considered negative and
score 3 was considered positive. Adenomatous parathyroid
glands that showed radiotracer activity on the scans were
defined as true-positive findings. Nonparathyroid lesions,
especially thyroid nodules or normal parathyroid glands
without abnormal radiotracer activity on the scans, were
defined as true-negative findings. Activity in a nonpara-
thyroid lesion, especially in a thyroid nodule that showed
radiotracer activity on the scans, was defined as a false-
positive (FP) finding. A parathyroid lesion confirmed by
surgery, which had not been identified by imaging tech-
niques, was defined as a false-negative result. Sensitivity,
specificity, negative and positive predictive values, and
accuracy were determined on a per-parathyroid-gland basis
for each scan method, as defined by histology and follow-
up (normal PTH level and calcaemia). The McNemar test
was used to compare the statistical parameters of the three
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methods: planar, SPECT, and SPECT-CT. A P-value of less
than 0.05 was considered significant. Statistical analysis
was performed using an IBM computer and MedCalc
software, version 11.3 (MedCalc Software, Mariakerke,
Belgium), and also PASW software, version 18.0 (SPSS
Inc., Chicago, Illinois, USA).
Results
The surgery was successful in 48 of 50 patients with
primary hyperparathyroidism concomitant with thyroid
nodularity, and data were completed for 80 sites in 48
patients. Two patients who underwent unsuccessful
surgery had thyroid nodules, and one included a papillary
carcinoma. All except one case required only one opera-
tion. In total, 49 parathyroid adenomas were detected in 48
cases. Three patients had MEN 1 syndrome. There were
38 cases of multinodular goiter, eight large multinodular
goiters (>100 g), and two patients with nodular goiters
upon clinical examination by an expert endocrinologist,
with all findings confirmed on CT scans.
The study included 33 women and 15 men (mean age:
59.44±11.29; range: 30–85 years).
The mean calcium level was 11.22±0.74mg/dl (normal
range: 9–10.5mg/dl), phosphor level was 2.73±0.49mg/dl
(normal range: 2.5–4.5mg/dl), and PTH level was
251.89±405.23 pg/ml (normal range: 15–65 g/ml). The
mean size of adenoma was 16.00±9.29mm.
The location of adenoma as reported in the surgical note
was as follows: 13 adenomas in the lower left thyroid lobe,
seven adenomas in the left upper thyroid lobe, four
adenomas in the right upper thyroid lobe, 17 adenomas
in the right lower thyroid lobe, two adenomas in the
thyrothymic ligament, four adenomas in the tracheoeso-
phageal groove, one adenoma in the aortopulmonary
window, and one adenoma in the thymus.
Furthermore, the precise localization of parathyroid
adenoma as seen on SPECT and SPECT-CT findings
according to its exact location on surgery was compared.
SPECT-CT relative to SPECT showed nine sites with
better localization, as follows: three adenomas in the right
lower thyroid lobe, one adenoma in the left lower thyroid
lobe, one adenoma in the thyrothymic ligament (Fig. 1),
three adenomas in the tracheoesophageal groove (Fig. 2),
and one adenoma in the thymus.
Both SPECTand SPECT-CTshowed good sensitivity and
specificity for the diagnosis of parathyroid adenoma
(Table 1). The accuracy of planar, SPECT, and SPECT-
CT in the diagnosis of parathyroid adenoma was 66.25,
75.00, and 85.00%, respectively.
The accuracy of SPECT-CT in correctly identifying a
parathyroid adenoma was 85.00 versus 75.00% for SPECT
(P=0.01, significant). The sensitivity and specificity for
this attribute were 77.55 and 96.77%, respectively, for
SPECT-CT, compared with 67.34 and 87.09%, respec-
tively, for SPECT (P=0.12 and 0.12, not significant)
(Table 1).
In addition, SPECT-CT showed higher sensitivity, speci-
ficity, and accuracy compared with the planar method
(P=0.01, 0.02, and 0.00, respectively) (Table 1). Further-
more, SPECT did not show a statistically significant
sensitivity, specificity, or accuracy relative to the planar
method (P=0.34, 0.50, and 0.16, respectively).
Discussion
As there is an increasing trend toward unilateral or
limited surgical neck explorations for the treatment of
primary hyperparathyroidism, preoperative detection
and localization investigations have become necessary
to distinguish single-gland from multigland disease,
to differentiate concomitant thyroid pathology, and also
to identify eutopic and ectopic parathyroid lesions [16].
In this context, sestamibi imaging as a widely accepted
technique shows the identification of hyperfunctioning
parathyroid glands on the basis of their activity. How-
ever, there are three main scintigraphic methods, in-
cluding planar, SPECT, or SPECT-CT, and there is not
sufficient evidence for SPECT-CT use in routine
practice [14,17].
Planar MIBI scintigraphy has typically been the primary
imaging technique for preoperative localization of adeno-
mas, with a sensitivity range of 74–87% [18]. Previous
studies have demonstrated greater sensitivity using
MIBI-SPECT [4,19,20].
Recently, as an alternative approach, hybrid SPECT-CT,
which incorporates a SPECT camera with a CT scanner
in a single apparatus, has the benefit of sequentially
obtaining SPECT and CT projections of the patient in
the same position on a single imaging bed [14].
Our present study suggests that the SPECT-CT modality
is more accurate than planar and SPECT techniques for
parathyroid lesion localization, although the sensitivity
and specificity were not statistically significant alone.
This improvement in accuracy is mainly because of the
ability of SPECT-CT to better characterize SPECT
findings on the basis of their congruent CT findings [21].
In some cases, this leads to proper categorization of
SPECT findings either as sestamibi-avid nonparathyroid
lesions or as artificial findings, thus diminishing FP
findings.
In a comprehensive study by Lavely et al. [10], the three
main image acquisition techniques, planar imaging,
SPECT, and SPECT-CT scintigraphy, were applied to
98 patients with primary hyperparathyroidism resulting
from single adenomas and were compared with surgical
findings. For each patient, planar imaging, SPECT, and
SPECT-CT at 15min and 2 h after sestamibi administra-
tion were carried out. Parathyroid localization had a
sensitivity of 34% for single-phase early planar views,
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45% for single-phase delayed planar views, 57% for dual-
phase planar images, 54% for single-phase early SPECT, 54%
for single-phase delayed SPECT, and 62% for dual-phase
SPECT, which increased to 73% sensitivity for dual-phase
studies with early SPECT-CT. They recommended using
early SPECT-CT accompanied by any delayed (2h) imaging
method or dual-phase acquisition as a routine practice.
In our study, the dual-phase planar sensitivity was
59.18%, with an accuracy of 65.47%, which is similar to
the investigation by Lavely et al. [10]. The sensitivity for
single-phase early SPECTwas 67.34%, which is more than
the above and may be a result of testing a different
population.
Other studies have shown similar sensitivities with more
remarkable specificity for SPECT-CT in localizing para-
thyroid adenomas. In comparing SPECTwith SPECT-CT
images of 61 patients with primary hyperparathyroidism,
although the sensitivities of SPECT (71%) and SPECT-
CT (70%) were the same (P=0.779), the specificity of
SPECT-CT (96%) was considerably greater than that of
SPECT alone (48%; P=0.006) [14]. In another investi-
gation on 116 patients with a single adenoma, sensitivity
for SPECT-CT was 88% and that for SPECT was 59%.
Specificity for SPECT-CT was 99% and that for SPECT
was 95% [22]. Both studies demonstrated that SPECT-
CT fusion was superior to SPECT images alone in the
identification of parathyroid adenomas.
In a report on 28 patients undergoing reoperative surgery
for a ‘missed’ parathyroid gland, SPECT-CT was able to
predict the exact location of the abnormal gland in 86% of
patients, whereas sestamibi-SPECT was successful in
only 43% of cases (P<0.004) [23].
Further investigations demonstrated that hybrid SPECT-
CT imaging is often helpful in the detection and
localization of ectopic parathyroid adenomas [24].
Fig. 1
The planar methoxyisobutyl isonitrile scintigraphy of a 34-year-old patient with primary hyperparathyroidism and concomitant multinodular goiter at
20min (upper right) and 120min (bottom right) showing positive activity in the right lower lobe of the thyroid and equivocal activity in the left lower
lobe of the thyroid (arrows). The single photon emission computed tomography (SPECT) views (upper row) show localization of parathyroid
adenomas in the lower right and left thyroid lobes (arrows). The hybrid SPECT/computed tomography (CT) images on the lower row also show the
precise localization of the parathyroid adenoma in the left lower thyroid and also the thyrothymic ligament (arrows). The center row is a CT image of
the same patient. During surgery, an 8-mm-diameter adenoma in the thyrothymic ligament and a 9-mm adenoma in the left lower thyroid lobe were
excised.
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Another study, with participant characteristics similar to
those of ours, compared SPECT-CT with SPECT in 33
subgroups of patients with multinodular goiters and
primary hyperparathyroidism. After cervical ultrasounds,
all 33 patients underwent sestamibi planar scintigraphy,
but SPECTor SPECT-CTwas also performed on 18 or 15
patients, respectively [15]. SPECT-CT showed higher
sensitivity compared with SPECT (87.5 vs. 55.6%;
Fig. 2
20 min 6/7/2010 120 min 6/7/2010
The planar methoxyisobutyl isonitrile scintigraphy of a 61-year-old patient with primary hyperparathyroidism and concomitant multinodular goiter at
20min (center column of the upper row) and 120min (right column of the upper row) showing positive activity in the right lower lobe of the thyroid
and equivocal activity in the left lower lobe of the thyroid (arrows). The single photon emission computed tomography (SPECT) views (middle row)
show localization of the parathyroid adenoma in the posterior of the lower right lobe of the thyroid (arrow). The hybrid SPECT/computed tomography
(CT) images on the lower row show the precise localization of the parathyroid adenoma on the right side of the tracheoesophageal groove (arrow).
The left column of the upper row is a CT image of the same patient. During surgery, an 8.5-mm-diameter adenoma on the right side of the
tracheoesophageal groove was excised. The left lower activity on planar views was a thyroid nodule.
Table 1 The accuracy of different scintigraphy procedures in parathyroid adenoma diagnosis
True positive False positive True negative False negative Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Planar 29 7 24 20 59.18 77.41 80.55 54.54 66.25
SPECT 33 4 27 16 67.34 87.09 89.18 62.79 75.00
SPECT-CT 38 1 30 11 77.55 96.77 97.43 73.17 85.00
NPV, negative predictive value; PPV, positive predictive value; SPECT-CT, single photon emission computed tomography/computed tomography.
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P=0.0001) and also higher positive predictive value
(87.5 vs. 62.5%; P=0.0022) for correct detection of
parathyroid adenoma; although the specificity of SPECT-
CT was greater than of SPECT, it was not significant
(95.5 and 88.5%, respectively). They recommended that
SPECT-CT be routinely performed for patients with
primary hyperparathyroidism and multinodular goiter.
Our study showed a nonsignificant increase in the
sensitivity and specificity of SPECT-CT relative to
SPECT and a significant difference in accuracy, which
may have been because of a larger sample size in our
patient numbers.
Furthermore, Neumann et al. [14] compared the diag-
nostic accuracy of 99mTc-sestamibi/123I subtraction
SPECT with SPECT-CT for the identification of
abnormal parathyroid glands in patients with primary
hyperparathyroidism and showed only higher specificity
of SPECT-CT relative to SPECT. The sensitivities of
SPECT and SPECT-CT were similar (71 vs. 70%;
P>0.05). The specificity of SPECT-CTwas considerably
greater than that of SPECT (96 vs. 48%; P<0.05) [14].
In contrast, Gayed et al. [13] performed a comparison study
on 32 patients and concluded that SPECT-CT did not
provide remarkable additional clinical information to
conventional SPECT for parathyroid imaging, except in
locating ectopic parathyroid glands; in addition, omitting
the CT component of the SPECT-CT acquisition would
save time and reduce radiation exposure and expense [13].
In the current investigation, we detected nine adenomas
with better localization, including four eutopic and five
ectopic adenomas, in addition to better accuracy, which
could mainly be explained as a result of using a different
population sample. The localization was compared with
adjacent organs such as the thyroid gland, trachea,
esophagus, and great vessel. Similarly, in our investiga-
tion, SPECT-CT showed more lesions in all eutopic
adenomas, except in the left upper thyroid region and
five ectopic regions. The ability of SPECT-CT to detect
ectopic adenomas seems to be its major advantage.
Furthermore, when there is an abnormal activity in the
lower level of the thyroid in planar images, SPECT-CT
may help to distinguish a descended superior parathyroid
adenoma from an inferior parathyroid adenoma, which
cannot be differentiated on planar images [25]. It is the
most important point for surgeons so that they can
properly resect the adenoma. In the present study,
ectopic adenomas were found in eight of the 48 patients
(16.66%). This relatively high number of ectopic lesions,
compared with the 8–11% in the literature [26], may be
due to the initial referral bias of participants and could, in
part, be the reason for the noteworthy benefit provided
by SPECT-CT in the current study [1].
More investigations concluded that SPECT-CT improves
the ability to localize abnormal parathyroid glands, rather
than planar scintigraphy or SPECT alone. This valuable
role of SPECT-CT in general oncologic patients, includ-
ing those with parathyroid adenomas, is due to the
acquisition of both functional and anatomic images from
SPECT and CT, which has been demonstrated to be
synergistic as against complementary [27]. Because of
challenges in the acquisition of SPECT-CT and the
potential increase in patient radiation doses [22,24], the
benefits of its improved accuracy need to be evaluated by
future confirmatory imaging studies.
The accuracy of the studies in the detection of
parathyroid adenomas may be adversely affected by some
factors. In a study to assess the parameters that predicted
an accurate scan using a multivariate logistic regression
model, it was observed that a higher percentage of
oxyphil cells (P=0.03), heavier gland (P=0.03), female
sex (P=0.04), and gland location in the lower position
(P=0.04) were associated [28]. Another study showed
that a positive 99mTc-MIBI scan is most associated with
adenoma size and ionized calcium level [29], which will
be demonstrated later [14].
It also suggested that the accuracy of 99mTc-MIBI-
SPECT in the identification of residual hyperactive
glands is considerably lower before reoperative parathy-
roidectomy for persistent hyperparathyroidism than be-
fore initial surgery [30].
In addition, other studies demonstrated that failure of
sestamibi scans was more common in cases of primary
hyperparathyroidism with multinodular goiter [31].
Furthermore, patients with hypovitaminosis D are more
likely to reveal positive results on a sestamibi scan [32].
In brief, our study demonstrated a potentially higher
accuracy for SPECT-CT compared with planar and
SPECT scintigraphic procedures. Particularly, SPECT-
CT may decrease FP results attributable to thyroid
nodules and false-negative results attributed to adenoma
of a cystic nature or associated with concomitant thyroid
nodules, which may go unidentified by scintigraphy.
It also showed that SPECT-CT was able to validate the
inconclusive findings of SPECT or planar images.
Finally, it should be mentioned that, although the
findings of this study are encouraging, they must be
considered as groundwork because of the relatively small
sample size of our patient series. Hence, further well-
designed studies of patients with primary hyperparathy-
roidism, both with and without previous neck surgery, as
well as with and without thyroid nodularity, should be
implemented to confirm these findings.
Conclusion
The results of our study indicate that SPECT-CT is more
accurate than sestamibi planar and SPECT for the
preoperative identification of parathyroid lesions in
patients with primary hyperparathyroidism concomitant
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with thyroid nodularity. Also, we would recommend the
use of SPECT-CT for the workup of all patients with
ectopic glands who are scheduled for minimally invasive
parathyroid surgery. However, a larger study should be
conducted to assess the clinical procedures, cost-effec-
tiveness, and exposure rate of SPECT-CT relative to
SPECT.
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